Keywords: astrazeneca, iressa, oncology, compound, says, its, novel

AstraZeneca's Iressa "Oncology Compound of Year"

Article | 06 September 2004

Print This

AstraZeneca says that its novel anticancer agent Iressa (gefitinib) wasnamed the Oncology Compound of the Year, together with the USA's ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in